Melanoma Clinical Trials

Showing 1301-1320 of 1,477 trials

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma

NCT00012064

RATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to kill tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy in treating patients who have stage IV or recurrent melanoma.

Melanoma (Skin)

Lisata Therapeutics, Inc.56 participantsStarted Jul 2000

Newport Beach, California, United States

UNKNOWNPhase 1/2

Vaccine Therapy in Treating Patients With Metastatic Melanoma

NCT00002817

RATIONALE: Vaccines may make the body build an immune response to kill melanoma cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy in treating patients with metastatic melanoma.

Melanoma (Skin)

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University30 participantsStarted Apr 1996

Philadelphia, Pennsylvania, United States

UNKNOWNPhase 1/2

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

NCT00004025

RATIONALE: Vaccines made from a person's white blood cells combined with melanoma antigens may make the body build an immune response to tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill melanoma cells. Combining vaccine therapy with interleukin-2 may be an effective treatment for stage III or stage IV melanoma. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy with or without interleukin-2 in treating patients who have stage III or stage IV melanoma that cannot be surgically removed.

Melanoma (Skin)

Genzyme, a Sanofi Company36 participantsStarted Mar 1999

Boston, Massachusetts, United States • Houston, Texas, United States

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Related Searches

SciBase International Melanoma Pivotal Study

Vaccine Therapy in Treating Patients With Malignant Melanoma

Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma

ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma

Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions

A Phase I/II Study of Dasatinib and Dacarbazine

Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors